Page 4 - Taiwanese (TAIEX) Growth Pharmaceuticals & Biotech Stocks

UPDATED Nov 27, 2024

Discover Taiwanese Pharmaceuticals & Biotech Growth Stocks that are on the TAIEX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

127 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

6696

Lin BioScience
NT$140.00-13.8%24.4%NT$11.0bn/aPB4.3xn/an/a

3716

Cenra
NT$37.85-0.8%n/aNT$5.6bn/aPE15.2xn/an/a

7427

Great Novel Therapeutics Biotech & Medicals
NT$35.65-1.8%-50.7%NT$1.6bn/aPS2526.6xn/an/a

1752

Nang Kuang Pharmaceutical
NT$43.400.6%-22.6%NT$4.4bn/aPE35.9xn/a4.6%

6810

Bio Preventive Medicine
NT$28.409.0%-26.2%NT$978.3mn/an/an/an/a

6620

Handa Pharmaceuticals
NT$54.60-6.8%-67.0%NT$7.7bNT$200.00PE17xn/a1.8%

6827

MegaPro Biomedical
NT$15.35-1.0%-42.3%NT$993.5mn/an/an/an/a

4132

Golden Biotechnology
NT$16.30-3.0%-58.2%NT$2.6bn/aPS46xn/an/a

6662

BioLASCO Taiwan
NT$35.400.3%9.9%NT$906.7mn/aPE21.3xn/a4.7%

6733

BioGend Therapeutics
NT$36.20-0.8%2.7%NT$4.5bNT$44.00PS28.7xS25.9%n/a

7762

Pet Pharm Biotech
NT$42.20-0.9%n/aNT$1.7bn/an/an/a0.5%

6661

Welgene BiotechLtd
NT$24.25-0.2%3.9%NT$565.1mn/aPS1.8xn/a0%

6704

Gwo Xi Stem Cell Applied Technology
NT$29.003.6%-15.3%NT$2.8bn/aPS18.5xn/an/a

6564

Enimmune
NT$28.901.0%-25.2%NT$2.1bn/aPS41xn/an/a

4130

Genovate Biotechnology
NT$21.75-0.9%-18.7%NT$2.5bn/aPE89.8xn/a0.7%

6541

Tanvex BioPharma
NT$66.70-4.4%-6.3%NT$11.1bn/aPS267.2xn/an/a

3164

GenMont Biotech Incorporation
NT$20.300.7%-16.8%NT$1.8bn/aPE33xn/a3.4%

6657

Energenesis BiomedicalLTD
NT$56.707.8%-14.4%NT$4.3bn/aPS585xn/an/a

6566

Chuang Yi Biotech
NT$5.200%-65.3%NT$176.5mn/aPB1.3xn/an/a

6949

Pell Bio-Med Technology
NT$86.50-3.7%n/aNT$5.0bn/aPS271.1xn/an/a

6634

Sinew Pharma
NT$50.00-0.2%-27.6%NT$3.6bn/aPB2.8xn/an/a

6936

Vetnostrum Animal Health
NT$37.80-0.3%-0.5%NT$2.5bn/an/an/a2.8%

6917

Andros PharmaceuticalsLtd
NT$18.8015.3%-23.7%NT$653.7mn/an/an/an/a

4195

Genomics BioSci & Tech.Ltd
NT$18.001.1%-13.7%NT$1.3bn/aPS3.1xn/a0%
Page 4 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.